Camilleri, Michael
Mayo Clinic
113 papers on CoChatORCID 0000-0001-6472-7514
Most cited papers
- Verified
GLP-1 Analog Modulates Appetite, Taste Preference, Gut Hormones, and Regional Body Fat Stores in Adults with Obesity
Kadouh, H., Chedid, V., Halawi, H., Burton, D. D., Clark, M. M., Khemani, D., Vella, A., Acosta, A., & Camilleri, M. (2020) · The Journal of Clinical Endocrinology & Metabolism
Regulation of Appetite and ObesityPharmacology and Obesity Treatment
Cited by 166
- Verified
Measurement of serum 7α‐hydroxy‐4‐cholesten‐3‐one (or 7αC4), a surrogate test for bile acid malabsorption in health, ileal disease and irritable bowel syndrome using liquid chromatography‐tandem mass spectrometry
Camilleri, M., Nadeau, A., Tremaine, W. J., Lamsam, J., Burton, D., Odunsi, S., Sweetser, S., & Singh, R. (2009) · Neurogastroenterology & Motility
Gastrointestinal motility and disordersInflammatory Bowel Disease
Cited by 153
- Verified
Gastroparesis
Camilleri, M., & Sanders, K. M. (2022) · Gastroenterology
Gastrointestinal motility and disordersGastroesophageal reflux and treatments
Cited by 151
- Verified
A community-based, controlled study of the epidemiology and pathophysiology of dyspepsia
Castillo, E. J., Camilleri, M., Locke, G. R., Burton, D. D., Stephens, D. A., Geno, D. M., & Zinsmeister, A. R. (2004) · Clinical Gastroenterology and Hepatology
Gastrointestinal motility and disordersHelicobacter pylori-related gastroenterology studies
Cited by 150
- Verified
Loss-of-Function of the Voltage-Gated Sodium Channel NaV1.5 (Channelopathies) in Patients With Irritable Bowel Syndrome
Beyder, A., Mazzone, A., Strege, P. R., Tester, D. J., Saito, Y. A., Bernard, C. E., Enders, F. T., Ek, W. E., Schmidt, P. T., Dlugosz, A., et al. (2014) · Gastroenterology
Gastrointestinal motility and disordersIon channel regulation and function
Cited by 144
- Verified
Gastrointestinal effects of GLP-1 receptor agonists: mechanisms, management, and future directions
Jalleh, R. J., Rayner, C. K., Hausken, T., Jones, K. L., Camilleri, M., & Horowitz, M. (2024) · The Lancet Gastroenterology & Hepatology
Diabetes Treatment and ManagementGastrointestinal motility and disorders
Cited by 144
- Verified
Fundamentals of Neurogastroenterology: Physiology/Motility – Sensation
Boeckxstaens, G., Camilleri, M., Sifrim, D., Houghton, L. A., Elsenbruch, S., Lindberg, G., Azpiroz, F., & Parkman, H. P. (2016) · Gastroenterology
Gastrointestinal motility and disordersGastroesophageal reflux and treatments
Cited by 142
- Verified
Lower functional gastrointestinal disorders: evidence of abnormal colonic transit in a 287 patient cohort
manabe, N., wong, B. S., camilleri, M., burton, D., mckinzie, S., & zinsmeister, A. R. (2010) · Neurogastroenterology & Motility
Gastrointestinal motility and disordersPelvic floor disorders treatments
Cited by 142
- Verified
Epidemiology, Etiology, and Treatment of Gastroparesis: Real-World Evidence From a Large US National Claims Database
Ye, Y., Yin, Y., Huh, S. Y., Almansa, C., Bennett, D., & Camilleri, M. (2022) · Gastroenterology
Gastrointestinal motility and disordersGastrointestinal Bleeding Diagnosis and Treatment
Cited by 142
- Verified
Autonomic dysfunction in gastrointestinal motility disorders
Bharucha, A. E., Camilleri, M., Low, P. A., & Zinsmeister, A. R. (1993) · Gut
Gastrointestinal motility and disordersHeart Rate Variability and Autonomic Control
Cited by 141
- Verified
Effects of liraglutide on gastrointestinal functions and weight in obesity: A randomized clinical and pharmacogenomic trial
Maselli, D., Atieh, J., Clark, M. M., Eckert, D., Taylor, A., Carlson, P., Burton, D. D., Busciglio, I., Harmsen, W. S., Vella, A., et al. (2022) · Obesity
Pharmacology and Obesity TreatmentRegulation of Appetite and Obesity
Cited by 136
- Verified
Effects of A3309, an ileal bile acid transporter inhibitor, on colonic transit and symptoms in females with functional constipation
Wong, B. S., Camilleri, M., McKinzie, S., Burton, D., Graffner, H., & Zinsmeister, A. R. (2011) · American Journal of Gastroenterology
Gastrointestinal motility and disordersPelvic floor disorders treatments
Cited by 133
- Verified
Alterations in mucosal immunity identified in the colon of patients with irritable bowel syndrome
Aerssens, J., Camilleri, M., Talloen, W., Thielemans, L., Göhlmann, H. W. H., Van den Wyngaert, I., Thielemans, T., De Hoogt, R., Andrews, C. N., Bharucha, A. E., et al. (2008) · Clinical Gastroenterology and Hepatology
Gastrointestinal motility and disordersGut microbiota and health
Cited by 124
- Verified
Actions and therapeutic pathways of ghrelin for gastrointestinal disorders
Camilleri, M., Papathanasopoulos, A., & Odunsi, S. T. (2009) · Nature Reviews Gastroenterology & Hepatology
Regulation of Appetite and ObesityGastrointestinal motility and disorders
Cited by 115
- Verified
Effect of Increased Bile Acid Synthesis or Fecal Excretion in Irritable Bowel Syndrome-Diarrhea
Camilleri, M., Busciglio, I., Acosta, A., Shin, A., Carlson, P., Burton, D., Ryks, M., Rhoten, D., Lamsam, J., Lueke, A., et al. (2014) · American Journal of Gastroenterology
Gastrointestinal motility and disordersGut microbiota and health
Cited by 114
- Verified
Effects of pramlintide, an amylin analogue, on gastric emptying in type 1 and 2 diabetes mellitus
VELLA, A., LEE, J. S., CAMILLERI, M., SZARKA, L. A., BURTON, D. D., ZINSMEISTER, A. R., RIZZA, R. A., & KLEIN, P. D. (2002) · Neurogastroenterology & Motility
Gastrointestinal motility and disordersDiabetes Treatment and Management
Cited by 112
- Verified
Probiotics and Irritable Bowel Syndrome: Rationale, Putative Mechanisms, and Evidence of Clinical Efficacy
Camilleri, M. (2006) · Journal of Clinical Gastroenterology
Gastrointestinal motility and disordersProbiotics and Fermented Foods
Cited by 106
- Verified
Comparison of the postural tachycardia syndrome (POTS) with orthostatic hypotension due to autonomic failure
Low, P. A., Opfer-Gehrking, T. L., Textor, S. C., Schondorf, R., Suarez, G. A., Fealey, R. D., & Camilleri, M. (1994) · Journal of the Autonomic Nervous System
Cardiovascular Syncope and Autonomic DisordersHeart Rate Variability and Autonomic Control
Cited by 105
- Verified
Relationship between glycemic control and gastric emptying in poorly controlled type 2 diabetes
Bharucha, A. E., Kudva, Y., Basu, A., Camilleri, M., Low, P. A., Vella, A., & Zinsmeister, A. R. (2015) · Clinical Gastroenterology and Hepatology
Gastrointestinal motility and disordersDiabetes Treatment and Management
Cited by 105
- Verified
Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: Society for Perioperative Assessment and Quality Improvement (SPAQI) multidisciplinary consensus statement
Oprea, A. D., Ostapenko, L. J., Sweitzer, B., Selzer, A., Irizarry-Alvarado, J. M., Hurtado Andrade, M. D., Mendez, C. E., Kelley, K. D., Stewart, E., Fernandez Robles, C. R., et al. (2025) · British Journal of Anaesthesia
Enhanced Recovery After SurgeryDiabetes Treatment and Management
Cited by 104
- Verified
Pharmacogenetic Trial of a Cannabinoid Agonist Shows Reduced Fasting Colonic Motility in Patients With Nonconstipated Irritable Bowel Syndrome
Wong, B. S., Camilleri, M., Busciglio, I., Carlson, P., Szarka, L. A., Burton, D., & Zinsmeister, A. R. (2011) · Gastroenterology
Gastrointestinal motility and disordersCannabis and Cannabinoid Research
Cited by 100
- Verified
Effects of glucagon-like peptide-1, yohimbine, and nitrergic modulation on sympathetic and parasympathetic activity in humans
Bharucha, A. E., Charkoudian, N., Andrews, C. N., Camilleri, M., Sletten, D., Zinsmeister, A. R., & Low, P. A. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
Heart Rate Variability and Autonomic ControlDiabetes Treatment and Management
Cited by 98
- Verified
Association of glucagon-like peptide 1 analogs and agonists administered for obesity with weight loss and adverse events: a systematic review and network meta-analysis
Vosoughi, K., Atieh, J., Khanna, L., Khoshbin, K., Prokop, L. J., Davitkov, P., Murad, M. H., & Camilleri, M. (2021) · eClinicalMedicine
Pharmacology and Obesity TreatmentDiabetes Treatment and Management
Cited by 97
- Verified
Increased Prevalence of Rare Sucrase-isomaltase Pathogenic Variants in Irritable Bowel Syndrome Patients
Garcia-Etxebarria, K., Zheng, T., Bonfiglio, F., Bujanda, L., Dlugosz, A., Lindberg, G., Schmidt, P. T., Karling, P., Ohlsson, B., Simren, M., et al. (2018) · Clinical Gastroenterology and Hepatology
Gastrointestinal motility and disordersDigestive system and related health
Cited by 96
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free